BG47197A3 - Method for preparing of 3- (hydroxymethyl)- isoquinoline derivatives - Google Patents

Method for preparing of 3- (hydroxymethyl)- isoquinoline derivatives

Info

Publication number
BG47197A3
BG47197A3 BG079834A BG7983487A BG47197A3 BG 47197 A3 BG47197 A3 BG 47197A3 BG 079834 A BG079834 A BG 079834A BG 7983487 A BG7983487 A BG 7983487A BG 47197 A3 BG47197 A3 BG 47197A3
Authority
BG
Bulgaria
Prior art keywords
hydroxymethyl
preparing
isoquinoline derivatives
heart failure
cardiotonic
Prior art date
Application number
BG079834A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gyoergy Rabloczky
Jenoe Koeroesi
Tibor Lang
Istvan Ling
Tamas Hamori
Maria Kuhar
Istvan Elekes
Peter Botka
Andras Varro
Sandor Elek
Judit Sarossy
Gabor Zolyomi
Zsuzsanna Lang
Imre Moravcsik
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of BG47197A3 publication Critical patent/BG47197A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG079834A 1986-05-21 1987-05-21 Method for preparing of 3- (hydroxymethyl)- isoquinoline derivatives BG47197A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU862141A HU196758B (en) 1986-05-21 1986-05-21 Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them

Publications (1)

Publication Number Publication Date
BG47197A3 true BG47197A3 (en) 1990-05-15

Family

ID=10957979

Family Applications (1)

Application Number Title Priority Date Filing Date
BG079834A BG47197A3 (en) 1986-05-21 1987-05-21 Method for preparing of 3- (hydroxymethyl)- isoquinoline derivatives

Country Status (22)

Country Link
US (1) US4785104A (xx)
JP (1) JPS6339863A (xx)
BE (1) BE1000719A4 (xx)
BG (1) BG47197A3 (xx)
CH (1) CH673280A5 (xx)
CS (1) CS264293B2 (xx)
DD (1) DD268940A5 (xx)
DE (1) DE3717079A1 (xx)
DK (1) DK258287A (xx)
ES (1) ES2005583A6 (xx)
FI (1) FI872256A (xx)
FR (1) FR2599033A1 (xx)
GB (1) GB2190678B (xx)
HU (1) HU196758B (xx)
IL (1) IL82614A0 (xx)
IT (1) IT1208046B (xx)
NL (1) NL8701214A (xx)
PL (1) PL265811A1 (xx)
PT (1) PT84924B (xx)
SE (1) SE8702119L (xx)
SU (1) SU1551245A3 (xx)
YU (1) YU90787A (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
CA2424292A1 (en) 2000-10-10 2002-04-18 Calyx Therapeutics, Inc. Tricyclic compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
FR2525595A1 (fr) * 1982-04-27 1983-10-28 Pharmuka Lab Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments

Also Published As

Publication number Publication date
GB2190678A (en) 1987-11-25
SE8702119D0 (sv) 1987-05-21
GB2190678B (en) 1990-06-20
IT8720618A0 (it) 1987-05-21
SE8702119L (sv) 1987-11-22
CS264293B2 (en) 1989-06-13
SU1551245A3 (ru) 1990-03-15
HUT44017A (en) 1988-01-28
DD268940A5 (de) 1989-06-14
CH673280A5 (xx) 1990-02-28
PL265811A1 (en) 1988-07-21
DE3717079A1 (de) 1988-01-07
HU196758B (en) 1989-01-30
GB8712047D0 (en) 1987-06-24
PT84924B (en) 1989-07-20
FI872256A (fi) 1987-11-22
CS369187A2 (en) 1988-09-16
US4785104A (en) 1988-11-15
ES2005583A6 (es) 1989-03-16
YU90787A (en) 1988-08-31
NL8701214A (nl) 1987-12-16
IL82614A0 (en) 1987-11-30
JPS6339863A (ja) 1988-02-20
IT1208046B (it) 1989-06-01
BE1000719A4 (fr) 1989-03-21
FI872256A0 (fi) 1987-05-21
DK258287A (da) 1987-11-22
FR2599033A1 (fr) 1987-11-27
PT84924A (en) 1987-06-01
DK258287D0 (da) 1987-05-21

Similar Documents

Publication Publication Date Title
IE38602L (en) Aryloxyalkanolamine derivatives
TNSN87086A1 (fr) Derives du nitrofuranne, leur preparation et leur application en therapeutique
NO820686L (no) Fremgangsmaate ved fremstilling av nye aroylimidazoloner
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
NO842835L (no) Fremgangsmaate ved fremstilling av nye imidazoliumsalter
SE7409387L (xx)
FR2415630A1 (fr) Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation
FI871087A (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
BG47197A3 (en) Method for preparing of 3- (hydroxymethyl)- isoquinoline derivatives
NO864514D0 (no) Fremgangsmaate for fremstilling av thiazoloner.
JPS5231592A (en) Embedded heart pacemaker electrode via venous blood
NO147876C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 2,2`-ditio-bis-(benzamid)-derivater eller salter derav
FR2421179A1 (fr) 3-0-(b-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
DE3686472D1 (de) Cardiotonische phenyloxazolone.
BG43187A3 (en) Method for preparing of auronic derivatives
AU499140B2 (en) Pharmaceutical preparations forthe treatment of coronary heart diseases
NO152253C (no) Analogifremgangsmaate for fremstlling av 4-(n-(3`,4`-dihydroksybenzyliden)aminometyl)-cykloheksan-1-karboksylsyre med terapeutisk aktivitet
IL58828A (en) 3-bromoisoxazole derivatives,the preparation of 1-(3-bromoisoxazol-5-yl)-2-tert.butylaminoethanol and pharmaceutical compositions containing it
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
FR2330400A1 (fr) Derives d'acides pyrimidine-7-carboxyliques substitues, leur preparation et leurs utilisations therapeutiques
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
FR2450835A2 (fr) Derives de la tetrahydroalstonine et leur application en therapeutique
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
NO154669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 10-bromsandwicin og 10-bromisosandwicin, samt syreaddisjonssalter derav.